Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cryo Cell International (CCEL) Income from Continuing Operations (2016 - 2025)

Cryo Cell International (CCEL) has disclosed Income from Continuing Operations for 16 consecutive years, with 8320201.0 as the latest value for Q4 2025.

  • On a quarterly basis, Income from Continuing Operations fell 282.26% to 8320201.0 in Q4 2025 year-over-year; TTM through Nov 2025 was 6932153.0, a 8056.93% decrease, with the full-year FY2025 number at 6932153.0, down 8056.93% from a year prior.
  • Income from Continuing Operations was 8320201.0 for Q4 2025 at Cryo Cell International, down from 749408.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 1170629.0 in Q2 2021 to a low of 16853844.0 in Q4 2023.
  • A 5-year average of 858779.9 and a median of 645254.5 in 2022 define the central range for Income from Continuing Operations.
  • Peak YoY movement for Income from Continuing Operations: surged 231.49% in 2022, then plummeted 2111.63% in 2023.
  • Cryo Cell International's Income from Continuing Operations stood at 637192.0 in 2021, then soared by 231.49% to 837822.0 in 2022, then tumbled by 2111.63% to 16853844.0 in 2023, then surged by 87.09% to 2176589.0 in 2024, then plummeted by 282.26% to 8320201.0 in 2025.
  • Per Business Quant, the three most recent readings for CCEL's Income from Continuing Operations are 8320201.0 (Q4 2025), 749408.0 (Q3 2025), and 355785.0 (Q2 2025).